According to our data, the therapeutic effect of Rapa-SLE-EVs was superior to that of Rapa-FBS-EVs, especially regarding inhibiting lymphatic hyperplasia and protecting kidney function. Here, TRERF1 is linked to systemic lupus erythematosus.